Matthias Cavassini

Matthias Cavassini

UNVERIFIED PROFILE

Are you Matthias Cavassini?   Register this Author

Register author
Matthias Cavassini

Matthias Cavassini

Publications by authors named "Matthias Cavassini"

Are you Matthias Cavassini?   Register this Author

99Publications

2545Reads

15Profile Views

Population pharmacokinetics of dolutegravir: influence of drug-drug interactions in a real-life setting.

J Antimicrob Chemother 2019 Sep;74(9):2690-2697

Service of Clinical Pharmacology, University Hospital Centre and University of Lausanne, Bugnon 17, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkz217DOI Listing
September 2019

Pharmacokinetic profiles of boosted darunavir, dolutegravir and lamivudine in aging patients enrolled in the Swiss HIV Cohort Study.

AIDS 2019 Sep 3. Epub 2019 Sep 3.

Division of Infectious Diseases and Hospital Epidemiology, Departments of Medicine and Clinical Research, University Hospital of Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000002372DOI Listing
September 2019

Pharmacokinetic profiles of boosted darunavir, dolutegravir and lamivudine in aging patients enrolled in the Swiss HIV Cohort Study.

AIDS 2019 Sep 3. Epub 2019 Sep 3.

Division of Infectious Diseases and Hospital Epidemiology, Departments of Medicine and Clinical Research, University Hospital of Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000002372DOI Listing
September 2019

The comparative effectiveness of NRTI-sparing dual regimens in emulated trials using observational data from the Swiss HIV Cohort Study.

Antivir Ther 2019 Apr 15. Epub 2019 Apr 15.

Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, University of Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP3310DOI Listing
April 2019

[Diagnosis, prevention and treatment of HIV : what's new in 2018 ?]

Rev Med Suisse 2019 Jan;15(N° 632-633):107-112

Unité VIH, Service des maladies infectieuses, HUG, 1211 Genéve 14.

View Article

Download full-text PDF

Source
January 2019

HIV and Aging - Perhaps Not as Dramatic as We Feared?

Gerontology 2018 15;64(5):446-456. Epub 2018 Jun 15.

University Department of Medicine and Infectious Diseases Service, Kantonsspital Baselland, University of Basel, Bruderholz, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000489172DOI Listing
December 2018

Non-targeted HIV testing in the emergency department: not just how but where.

Expert Rev Anti Infect Ther 2018 12 20;16(12):893-905. Epub 2018 Nov 20.

a Infectious Diseases Service , Lausanne University Hospital , Lausanne , Switzerland.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14787210.2018.1
Publisher Site
http://dx.doi.org/10.1080/14787210.2018.1545575DOI Listing
December 2018

Content analysis of antiretroviral adherence enhancing interview reports.

Patient Educ Couns 2018 09 17;101(9):1676-1682. Epub 2018 May 17.

Community Pharmacy, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland; Community Pharmacy, Department of Ambulatory Care & Community Medicine, University of Lausanne, Geneva, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pec.2018.05.013DOI Listing
September 2018

[Travelers' exposure to HIV and HIV-infected travelers].

Rev Med Suisse 2018 May;14(605):918-921

Service des maladies infectieuses, Département de médecine, CHUV, 1011 Lausanne.

View Article

Download full-text PDF

Source
May 2018

Single-Cell RNA-Seq Reveals Transcriptional Heterogeneity in Latent and Reactivated HIV-Infected Cells.

Cell Rep 2018 04;23(4):942-950

Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne 1011, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2018.03.102DOI Listing
April 2018

Are privacy-enhancing technologies for genomic data ready for the clinic? A survey of medical experts of the Swiss HIV Cohort Study.

J Biomed Inform 2018 03 10;79:1-6. Epub 2018 Jan 10.

School of Computer Communications Sciences, École Polytechnique Fédérale de Lausanne, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbi.2017.12.013DOI Listing
March 2018

Rivastigmine decreases brain damage in HIV patients with mild cognitive deficits.

Ann Clin Transl Neurol 2017 12 7;4(12):915-920. Epub 2017 Nov 7.

Department of Clinical Neurosciences, Service of Neurology, Neuroimmunology Unit Lausanne University Hospital and University of Lausanne Lausanne Vaud Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acn3.493DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740253PMC
December 2017

High prevalence of physical inactivity among patients from the Swiss HIV Cohort Study.

AIDS Care 2017 08 5;29(8):1056-1061. Epub 2017 Jan 5.

a Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, University of Basel , Basel , Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/09540121.2016.1274016DOI Listing
August 2017

Adverse events of raltegravir and dolutegravir.

AIDS 2017 08;31(13):1853-1858

aOspedale Regionale di Bellinzone e Valli, Bellinzona bDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel cDepartment of Infectious Diseases, University Hospital Bern, University of Bern dDivision of Infectious Diseases, University Hospital Lausanne, Lausanne eDivision of Infectious Diseases, University Hospital Geneva, Geneva fDivision of Infectious Diseases, Cantonal Hospital St Gallen, St Gallen gDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zürich, Zürich hInstitute of Medical Virology, University of Zürich, Zürich iDivision of Infectious Diseases, Regional Hospital Lugano, Lugano, Switzerland. *Luigia Elzi and Stefan Erb equally contributed to this article.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001590DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566167PMC
August 2017

Impact of screening and antiretroviral therapy on anal cancer incidence in HIV-positive MSM.

AIDS 2017 08;31(13):1859-1866

aInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland bDepartment of Mathematics, University of Bergen, Bergen, Norway cCheckpoint Zurich, Zurich dInstitute of Global Health, University of Geneva, Geneva eDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich fDivision of Infectious Diseases, University of Geneva, Geneva gDivision of Infectious Diseases and Hospital Epidemiology, University of Basel hBasel Institute for Clinical Epidemiology & Biostatistics, University Hospital Basel, Basel iDivision of Infectious Diseases, Department of Medicine, University Hospital of Lausanne, University of Lausanne, Lausanne, Switzerland jCentre for Infectious Disease Epidemiology and Research (CIDER), University of Cape Town, Cape Town, South Africa. *Nello Blaser, Barbara Bertisch, Olivia Keiser and Matthias Egger contributed equally to the article.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001546DOI Listing
August 2017

Late presentation to HIV care despite good access to health services: current epidemiological trends and how to do better.

Swiss Med Wkly 2016 21;146:w14348. Epub 2016 Aug 21.

Department of Infectious Diseases, Bern University Hospital, University of Bern, Switzerland; Institute of Social and Preventive Medicine, University of Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4414/smw.2016.14348DOI Listing
April 2017

Guidelines : fausse route ou voie dorée ?

Rev Med Suisse 2017 Apr;13(558):779-780

Service des maladies infectieuses, Département de médecine, CHUV, Lausanne.

View Article

Download full-text PDF

Source
April 2017

[Evaluation of an outpatient multidisciplinary Neuro-HIV clinic by the patients and referring doctors].

Rev Med Suisse 2017 Apr;13(558):782-786

Service des maladies infectieuses, Département de médecine, CHUV, 1011 Lausanne.

View Article

Download full-text PDF

Source
April 2017

Hepatitis delta-associated mortality in HIV/HBV-coinfected patients.

J Hepatol 2017 02 14;66(2):297-303. Epub 2016 Oct 14.

Department of Infectious Diseases, Bern University Hospital, University of Bern, Switzerland; Institute of Social and Preventive Medicine, University of Bern, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2016.10.007DOI Listing
February 2017

Human papillomavirus antibody response following HAART initiation among MSM.

AIDS 2017 02;31(4):561-569

aInternational Agency for Research on Cancer, Lyon, FrancebInstitute of Social and Preventive Medicine, University of Bern, BerncDivision of Infectious Diseases, University Hospital Lausanne, LausannedDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, BaseleDepartment of Infectious Diseases, Bern University Hospital, University of Bern, BernfHIV/AIDS Unit, Infectious Disease Service, Geneva University Hospital, GenevagDivision of Infectious Diseases, Cantonal Hospital St. Gallen, St. GallenhDivision of Infectious Diseases, Regional Hospital Lugano, LuganoiDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of ZurichjInstitute of Medical Virology, University of Zurich, Zurich, SwitzerlandkInfection and Cancer Program, German Cancer Research Center, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001354DOI Listing
February 2017

Hepatitis C Infection and the Risk of Non-Liver-Related Morbidity and Mortality in HIV-Infected Persons in the Swiss HIV Cohort Study.

Clin Infect Dis 2017 02;64(4):490-497

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciw809DOI Listing
February 2017

Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals.

Antimicrob Agents Chemother 2017 01 27;61(1). Epub 2016 Dec 27.

Division of Clinical Pharmacology, University Hospital Center, University of Lausanne, Lausanne, Switzerland

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.00899-16DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192124PMC
January 2017

Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population.

AIDS 2017 01;31(3):427-436

aInstitute of Social and Preventive Medicine (ISPM) bDepartment of Geriatrics, Inselspital, Bern University Hospital, University of Bern cDivision of Infectious Diseases, University of Geneva, Geneva dDivision of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich eInstitute of Medical Virology, University of Zurich, Zurich fDivision of Infectious Diseases, Regional Hospital Lugano, Lugano gDepartment of Infectious Diseases, Bern University Hospital, and University of Bern hDivision of Infectious Diseases, Cantonal Hospital Aarau, Aarau iDivision of Infectious Diseases & Hospital Epidemiology, University of Basel, Basel jDivision of Infectious Diseases, Department of Medicine, University Hospital of Lausanne, University of Lausanne, Lausanne kDivision of Infectious Diseases, Cantonal Hospital of St. Gallen, St. Gallen, Switzerland lCentre for Infectious Disease Epidemiology and Research (CIDER), University of Cape Town, Cape Town, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001335DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302412PMC
January 2017

Investigating Barriers in HIV-Testing Oncology Patients: The IBITOP Study, Phase I.

Oncologist 2016 10 20;21(10):1176-1182. Epub 2016 Jul 20.

Infectious Diseases Service, Department of Medicine, Lausanne University Hospital, Lausanne, Switzerland

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2016-0107DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061530PMC
October 2016

Development of an algorithm for analysing the electronic measurement of medication adherence in routine HIV care.

Int J Clin Pharm 2016 Oct 29;38(5):1210-8. Epub 2016 Jul 29.

Community Pharmacy, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11096-016-0354-xDOI Listing
October 2016

CD4/CD8 ratio and CD8 counts predict CD4 response in HIV-1-infected drug naive and in patients on cART.

Medicine (Baltimore) 2016 Oct;95(42):e5094

aEpidemiology, Biostatistics and Prevention Institute, University of Zurich, Switzerland bDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Switzerland cInstitute of Medical Virology, University of Zurich, Switzerland dDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Switzerland eDivision of Infectious Diseases, Regional Hospital Lugano, Switzerland fDivision of Infectious Diseases, University Hospital Lausanne, Switzerland gDepartment of Infectious Diseases, Bern University Hospital, University of Bern, Switzerland hDivision of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, Switzerland iDivision of Infectious Diseases, University Hospital Geneva, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000005094DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079322PMC
October 2016

Comparison of Population Pharmacokinetics Based on Steady-State Assumption Versus Electronically Monitored Adherence to Lopinavir, Atazanavir, Efavirenz, and Etravirine: A Retrospective Study.

Ther Drug Monit 2016 08;38(4):506-15

*Division of Clinical Pharmacology, Service of Biomedicine, Department of Laboratory, Lausanne University Hospital and University of Lausanne, Lausanne; †Division of Paediatric Pharmacology and Pharmacometrics, University of Basel Children's Hospital; ‡School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva; §Community Pharmacy, Department of Ambulatory Care & Community Medicine, University of Lausanne, Lausanne; and ¶Infectious Disease Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FTD.0000000000000297DOI Listing
August 2016

Association of disclosure of HIV status with medication adherence.

Patient Educ Couns 2016 08 17;99(8):1413-20. Epub 2016 Mar 17.

Community pharmacy, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland; Community pharmacy, Department of Ambulatory Care & Community Medicine, University of Lausanne, Lausanne, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pec.2016.03.012DOI Listing
August 2016

Successful Prevention of Transmission of Integrase Resistance in the Swiss HIV Cohort Study.

J Infect Dis 2016 08 29;214(3):399-402. Epub 2016 Apr 29.

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Institute of Medical Virology, University of Zurich.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jiw165DOI Listing
August 2016

[Emergency medicine and prevention : a contradiction in terms ? Observations based on HIV screening].

Rev Med Suisse 2016 Aug;12(526):1331-1335

Service des maladies infectieuses, CHUV, 1011 Lausanne.

View Article

Download full-text PDF

Source
August 2016

Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals.

J Antimicrob Chemother 2016 07 29;71(7):1933-42. Epub 2016 Mar 29.

Division of Clinical Pharmacology, University Hospital Centre and University of Lausanne, Lausanne, Switzerland School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkw050DOI Listing
July 2016

PD-1(+) and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals.

Nat Med 2016 07 30;22(7):754-61. Epub 2016 May 30.

Service of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm.4113DOI Listing
July 2016

In Vitro Reactivation of Replication-Competent and Infectious HIV-1 by Histone Deacetylase Inhibitors.

J Virol 2016 02 9;90(4):1858-71. Epub 2015 Dec 9.

Service of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.02359-15DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733986PMC
February 2016

In Vivo Profiling and Distribution of Known and Novel Phase I and Phase II Metabolites of Efavirenz in Plasma, Urine, and Cerebrospinal Fluid.

Drug Metab Dispos 2016 Jan 9;44(1):151-61. Epub 2015 Nov 9.

Laboratory of Clinical Pharmacology, Service of Biomedicine (M.A., B.T., M.R., L.A.D.), Division of Clinical Pharmacology, Service of Biomedicine (M.A., C.B., T.B.), Service of Infectious Diseases (B.T., M.C.), Institute of Microbiology (A.T., M.R.), and Innovation and Development, Service of Biomedicine (H.H.), University Hospital and University of Lausanne, Lausanne, Switzerland; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zürich, University of Zürich, Zürich, Switzerland (A.A., H.F.G.); Institute of Medical Virology, University of Zurich, Zurich, Switzerland (H.F.G.); Division of Infectious Diseases, Cantonal Hospital, St. Gallen, Switzerland (P.V.); Laboratory of Virology, University Hospital of Geneva, Geneva, Switzerland (S.Y.); and The J. Craig Venter Institute, La Jolla, California (A.T.)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/dmd.115.065839DOI Listing
January 2016

Hepatitis C Virus Awareness Among Men Who Have Sex With Men in Southwest Switzerland.

Sex Transm Dis 2016 Jan;43(1):44-8

From the *Infectious Diseases Service and †Institute of Social and Preventive Medicine, Lausanne University Hospital, Lausanne, Switzerland; and ‡HIV Unit, Division of Infectious Diseases, Geneva University Hospital, Geneva, Switzerland.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/stdjournal/2016/01000/Hepatitis
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/OLQ.0000000000000378DOI Listing
January 2016

Ability to Work and Employment Rates in Human Immunodeficiency Virus (HIV)-1-Infected Individuals Receiving Combination Antiretroviral Therapy: The Swiss HIV Cohort Study.

Open Forum Infect Dis 2016 Jan 1;3(1):ofw022. Epub 2016 Feb 1.

Division of Infectious Diseases and Hospital Epidemiology, Departments of Medicine and Clinical Research , University Hospital Basel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ofid/ofw022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777901PMC
January 2016

Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study.

J Antimicrob Chemother 2015 Dec 11;70(12):3323-31. Epub 2015 Sep 11.

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland Institute of Medical Virology, University of Zurich, Zurich, Switzerland

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkv257DOI Listing
December 2015

The HIV care cascade in Switzerland: reaching the UNAIDS/WHO targets for patients diagnosed with HIV.

AIDS 2015 Nov;29(18):2509-15

aDivision of Infectious Diseases and Infection Control, Cantonal Hospital St. Gallen bDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich cCommunicable Diseases Division, Federal Office of Public Health (FOPH), Bern, Switzerland dDepartment of Social and Environmental Health Research, London School of Hygiene and Tropical Medicine, UK eDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Lausanne fUniversity Clinic of Infectious Diseases, University Hospital Bern gHIV Unit, Geneva University Hospital, Geneva hDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Basel iOspedale Regionale, Lugano, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000878DOI Listing
November 2015

High hepatic and extrahepatic mortality and low treatment uptake in HCV-coinfected persons in the Swiss HIV cohort study between 2001 and 2013.

J Hepatol 2015 Sep 1;63(3):573-80. Epub 2015 May 1.

University Clinic of Infectious Diseases, University Hospital Berne and University of Berne, Berne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2015.04.019DOI Listing
September 2015

Strong Impact of Smoking on Multimorbidity and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Individuals in Comparison With the General Population.

Authors:
Barbara Hasse Philip E Tarr Pedro Marques-Vidal Gerard Waeber Martin Preisig Vincent Mooser Fabio Valeri Sima Djalali Rauch Andri Enos Bernasconi Alexandra Calmy Matthias Cavassini Pietro Vernazza Manuel Battegay Rainer Weber Oliver Senn Peter Vollenweider Bruno Ledergerber V Aubert J Barth M Battegay E Bernasconi J Böni H C Bucher C Burton-Jeangros A Calmy M Cavassini M Egger L Elzi J Fehr J Fellay H Furrer C A Fux M Gorgievski H Günthard D Haerry B Hasse H H Hirsch I Hösli C Kahlert L Kaiser O Keiser T Klimkait R Kouyos H Kovari B Ledergerber G Martinetti B Martinez de Tejada K Metzner N Müller D Nadal G Pantaleo A Rauch S Regenass M Rickenbach C Rudin F Schöni-Affolter P Schmid D Schultze J Schüpbach R Speck C Staehelin P Tarr A Telenti A Trkola P Vernazza R Weber S Yerly Aubry Jean-Michel Bochud Murielle Gaspoz Jean Michel Hock Christoph Lüscher Thomas Marques Vidal Pedro Mooser Vincent Paccaud Fred Preisig Martin Vollenweider Peter Von Känel Roland Vladeta Aidacic Waeber Gerard Beriger Jürg Bertschi Markus Bhend Heinz Büchi Martin Bürke Hans-Ulrich Bugmann Ivo Cadisch Reto Charles Isabelle Chmiel Corinne Djalali Sima Duner Peter Erni Simone Forster Andrea Frei Markus Frey Claudius Frey Jakob Gibreil Musa Ali Günthard Matthias Haller Denis Hanselmann Marcel Häuptli Walter Heininger Simon Huber Felix Hufschmid Paul Kaiser Eva Kaplan Vladimir Klaus Daniel Koch Stephan Köstner Beat Kuster Benedict Kuster Heidi Ladan Vesna Lauffer Giovanni Leibundgut Hans Werner Luchsinger Phillippe Lüscher Severin Maier Christoph Martin Jürgen Meli Damian Messerli Werner Morger Titus Navarro Valentina Rizzi Jakob Rosemann Thomas Sajdl Hana Schindelek Frank Schlatter Georg Senn Oliver Somaini Pietro Staeger Jacques Staehelin Alfred Steinegger Alois Steurer Claudia Suter Othmar Truong The Phuoc Vecellio Marco Violi Alessandro Von Allmen René Waeckerlin Hans Weber Fritz Weber-Schär Johanna Widler Joseph Zoller Marco

Open Forum Infect Dis 2015 Sep 8;2(3):ofv108. Epub 2015 Jul 8.

Division of Infectious Diseases and Hospital Epidemiology , University of Zurich, University Hospital Zurich.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ofid/ofv108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536331PMC
September 2015

Effect of Cumulating Exposure to Abacavir on the Risk of Cardiovascular Disease Events in Patients From the Swiss HIV Cohort Study.

J Acquir Immune Defic Syndr 2015 Aug;69(4):413-21

*Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, Switzerland; †Analysis Group Inc, Montreal, QC, Canada; ‡Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada; §Department of Medicine, Royal Victoria Hospital, McGill University Health Centre, Montreal, QC, Canada; ‖Division of Infectious Diseases, Regional Hospital of Lugano, Lugano, Switzerland; ¶Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland; #Division of Infectious Diseases, University Hospital Geneva, Geneva, Switzerland; **Division of Infectious Diseases, University Hospital Lausanne, Lausanne, Switzerland; ††Department of Infectious Diseases, Bern University Hospital and University of Bern, Bern, Switzerland; ‡‡Division of Infectious Diseases and Hospital Epidemiology, University Hospital and University of Zürich, Zürich, Switzerland; and §§Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://www.shcs.ch/userfiles/file/news/Young_Effect_of_cumul
Web Search
http://boris.unibe.ch/68974/1/00126334-900000000-97585.pdf
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/QAI.0000000000000662DOI Listing
August 2015